Connection

CRAIG LOGSDON to Mice

This is a "connection" page, showing publications CRAIG LOGSDON has written about Mice.
Connection Strength

0.836
  1. Transgenic Expression of PRSS1R122H Sensitizes Mice to Pancreatitis. Gastroenterology. 2020 03; 158(4):1072-1082.e7.
    View in: PubMed
    Score: 0.038
  2. RAGE maintains high levels of NF?B and oncogenic Kras activity in pancreatic cancer. Biochem Biophys Res Commun. 2017 11 04; 493(1):592-597.
    View in: PubMed
    Score: 0.033
  3. Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53. Oncogene. 2017 06 01; 36(22):3149-3158.
    View in: PubMed
    Score: 0.032
  4. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo. PLoS One. 2015; 10(12):e0144969.
    View in: PubMed
    Score: 0.030
  5. Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics. Am J Physiol Gastrointest Liver Physiol. 2015 Sep 01; 309(5):G283-91.
    View in: PubMed
    Score: 0.029
  6. Targeting pancreatic ductal adenocarcinoma acidic microenvironment. Sci Rep. 2014 Mar 19; 4:4410.
    View in: PubMed
    Score: 0.026
  7. Oncogenic K-Ras requires activation for enhanced activity. Oncogene. 2014 Jan 23; 33(4):532-5.
    View in: PubMed
    Score: 0.024
  8. Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy. Mol Cancer Ther. 2013 May; 12(5):654-62.
    View in: PubMed
    Score: 0.024
  9. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis. Clin Cancer Res. 2012 Aug 15; 18(16):4356-64.
    View in: PubMed
    Score: 0.023
  10. An NF-?B pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest. 2012 Apr; 122(4):1519-28.
    View in: PubMed
    Score: 0.023
  11. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models. Gut. 2012 Sep; 61(9):1315-22.
    View in: PubMed
    Score: 0.022
  12. Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis. Pancreas. 2011 Aug; 40(6):815-22.
    View in: PubMed
    Score: 0.022
  13. Chemoprevention of pancreatic cancer: ready for the clinic? Cancer Prev Res (Phila). 2010 Nov; 3(11):1375-8.
    View in: PubMed
    Score: 0.021
  14. The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment. PLoS One. 2009 Oct 22; 4(10):e7502.
    View in: PubMed
    Score: 0.019
  15. Ras activity levels control the development of pancreatic diseases. Gastroenterology. 2009 Sep; 137(3):1072-82, 1082.e1-6.
    View in: PubMed
    Score: 0.019
  16. Intracellular trypsin induces pancreatic acinar cell death but not NF-kappaB activation. J Biol Chem. 2009 Jun 26; 284(26):17488-98.
    View in: PubMed
    Score: 0.019
  17. Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells. Clin Cancer Res. 2008 Dec 15; 14(24):8143-51.
    View in: PubMed
    Score: 0.018
  18. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res. 2008 Oct 01; 68(19):7811-8.
    View in: PubMed
    Score: 0.018
  19. Robust acinar cell transgene expression of CreErT via BAC recombineering. Genesis. 2008 Aug; 46(8):390-5.
    View in: PubMed
    Score: 0.018
  20. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Cancer Res. 2007 Mar 15; 67(6):2666-75.
    View in: PubMed
    Score: 0.016
  21. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst. 2006 Dec 20; 98(24):1806-18.
    View in: PubMed
    Score: 0.016
  22. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res. 2005 Aug 01; 11(15):5356-64.
    View in: PubMed
    Score: 0.014
  23. Early elevations of RAS protein level and activity are critical for the development of PDAC in the context of inflammation. Cancer Lett. 2024 Apr 01; 586:216694.
    View in: PubMed
    Score: 0.013
  24. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem. 2004 Feb 13; 279(7):5059-65.
    View in: PubMed
    Score: 0.013
  25. Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer. Lab Invest. 2021 02; 101(2):177-192.
    View in: PubMed
    Score: 0.010
  26. Species differences between rat and mouse CCKA receptors determine the divergent acinar cell response to the cholecystokinin analog JMV-180. J Biol Chem. 2000 Jun 23; 275(25):19115-20.
    View in: PubMed
    Score: 0.010
  27. DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters. Cell Rep. 2019 12 10; 29(11):3448-3459.e6.
    View in: PubMed
    Score: 0.010
  28. The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer. Cell Rep. 2019 10 22; 29(4):889-903.e10.
    View in: PubMed
    Score: 0.010
  29. Muscarinic cholinergic receptors activate both inhibitory and stimulatory growth mechanisms in NIH3T3 cells. J Biol Chem. 1999 Jul 30; 274(31):21701-6.
    View in: PubMed
    Score: 0.010
  30. Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS. Cell Commun Signal. 2019 02 28; 17(1):19.
    View in: PubMed
    Score: 0.009
  31. CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cells. Am J Physiol. 1997 11; 273(5):C1449-57.
    View in: PubMed
    Score: 0.008
  32. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment. Cancer Res. 2017 05 15; 77(10):2647-2660.
    View in: PubMed
    Score: 0.008
  33. New Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice. Mol Cancer Ther. 2015 Apr; 14(4):941-51.
    View in: PubMed
    Score: 0.007
  34. Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2014 Nov; 13(11):2583-94.
    View in: PubMed
    Score: 0.007
  35. Preliminary evaluation of 1'-[(18)F]fluoroethyl-?-D-lactose ([(18)F]FEL) for detection of pancreatic cancer in nude mouse orthotopic xenografts. Nucl Med Biol. 2014 Nov-Dec; 41(10):833-40.
    View in: PubMed
    Score: 0.007
  36. Dietary energy balance modulation of Kras- and Ink4a/Arf+/--driven pancreatic cancer: the role of insulin-like growth factor-I. Cancer Prev Res (Phila). 2013 Oct; 6(10):1046-55.
    View in: PubMed
    Score: 0.006
  37. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology. 2013 Dec; 145(6):1449-58.
    View in: PubMed
    Score: 0.006
  38. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. EMBO Mol Med. 2013 Sep; 5(9):1322-34.
    View in: PubMed
    Score: 0.006
  39. Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. Cancer Res. 2013 Jul 01; 73(13):3927-37.
    View in: PubMed
    Score: 0.006
  40. Pancreatic cancer-associated Cathepsin E as a drug activator. J Control Release. 2013 May 10; 167(3):221-7.
    View in: PubMed
    Score: 0.006
  41. Study human pancreatic cancer in mice: how close are they? Biochim Biophys Acta. 2013 Jan; 1835(1):110-8.
    View in: PubMed
    Score: 0.006
  42. Activation of nuclear factor-?B in acinar cells increases the severity of pancreatitis in mice. Gastroenterology. 2013 Jan; 144(1):202-10.
    View in: PubMed
    Score: 0.006
  43. Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in ? cells and mice. Gastroenterology. 2012 Dec; 143(6):1510-1517.e1.
    View in: PubMed
    Score: 0.006
  44. Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling. PLoS One. 2012; 7(8):e42699.
    View in: PubMed
    Score: 0.006
  45. Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer. Mol Cancer Res. 2012 Sep; 10(9):1147-57.
    View in: PubMed
    Score: 0.006
  46. Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer. PLoS One. 2012; 7(7):e40420.
    View in: PubMed
    Score: 0.006
  47. A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis. Cancer Res. 2012 Feb 01; 72(3):655-65.
    View in: PubMed
    Score: 0.006
  48. Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2011 Nov 15; 17(22):7015-23.
    View in: PubMed
    Score: 0.006
  49. Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe. Mol Biosyst. 2011 Dec; 7(12):3207-3213.
    View in: PubMed
    Score: 0.006
  50. Duct cells contribute to regeneration of endocrine and acinar cells following pancreatic damage in adult mice. Gastroenterology. 2011 Oct; 141(4):1451-62, 1462.e1-6.
    View in: PubMed
    Score: 0.005
  51. Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy. Ann Surg Oncol. 2012 Jul; 19 Suppl 3:S395-403.
    View in: PubMed
    Score: 0.005
  52. Synthesis and ex vivo autoradiographic evaluation of ethyl-?-D-galactopyranosyl-(1,4')-2'-deoxy-2'-[18F]fluoro-?-D-glucopyranoside--a novel radioligand for lactose-binding protein: implications for early detection of pancreatic carcinomas with PET. Mol Imaging Biol. 2011 Jun; 13(3):536-546.
    View in: PubMed
    Score: 0.005
  53. Intracellular activation of trypsinogen in transgenic mice induces acute but not chronic pancreatitis. Gut. 2011 Oct; 60(10):1379-88.
    View in: PubMed
    Score: 0.005
  54. Phenotypic changes in mouse pancreatic stellate cell Ca2+ signaling events following activation in culture and in a disease model of pancreatitis. Mol Biol Cell. 2011 Feb 01; 22(3):421-36.
    View in: PubMed
    Score: 0.005
  55. Regulator of calcineurin 1 controls growth plasticity of adult pancreas. Gastroenterology. 2010 Aug; 139(2):609-19, 619.e1-6.
    View in: PubMed
    Score: 0.005
  56. ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB. Clin Cancer Res. 2010 Mar 01; 16(5):1423-30.
    View in: PubMed
    Score: 0.005
  57. Pancreatic acinar cells in culture: expression of acinar and ductal antigens in a growth-related manner. Eur J Cell Biol. 1990 Feb; 51(1):64-75.
    View in: PubMed
    Score: 0.005
  58. Detection of pancreatic carcinomas by imaging lactose-binding protein expression in peritumoral pancreas using [18F]fluoroethyl-deoxylactose PET/CT. PLoS One. 2009 Nov 24; 4(11):e7977.
    View in: PubMed
    Score: 0.005
  59. Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res. 2009 Oct 01; 15(19):5993-6001.
    View in: PubMed
    Score: 0.005
  60. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J Natl Cancer Inst. 2008 Jan 16; 100(2):109-20.
    View in: PubMed
    Score: 0.004
  61. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A. 2007 Nov 20; 104(47):18636-41.
    View in: PubMed
    Score: 0.004
  62. Effects of calcium mediated secretagogues on the growth of pancreatic acinar cells in vitro. Gut. 1987; 28 Suppl:117-20.
    View in: PubMed
    Score: 0.004
  63. Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro. Am J Physiol. 1986 Oct; 251(4 Pt 1):G487-94.
    View in: PubMed
    Score: 0.004
  64. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells. Mol Cancer Ther. 2006 Sep; 5(9):2251-60.
    View in: PubMed
    Score: 0.004
  65. Induction of inflammatory bowel disease accelerates adenoma formation in Min +/- mice. Surgery. 2006 Jun; 139(6):782-8.
    View in: PubMed
    Score: 0.004
  66. Islet hypertrophy following pancreatic disruption of Smad4 signaling. Am J Physiol Endocrinol Metab. 2006 Dec; 291(6):E1305-16.
    View in: PubMed
    Score: 0.004
  67. Pancreatic acinar cells in monolayer culture: direct trophic effects of caerulein in vitro. Am J Physiol. 1986 Apr; 250(4 Pt 1):G440-7.
    View in: PubMed
    Score: 0.004
  68. Improved retention of zymogen granules in cultured murine pancreatic acinar cells and induction of acinar-ductal transdifferentiation in vitro. Pancreas. 2005 Mar; 30(2):148-57.
    View in: PubMed
    Score: 0.004
  69. Sphingosine-1-phosphate induces early response gene expression in C6 glioma cells. Brain Res Mol Brain Res. 2005 Feb 18; 133(2):325-8.
    View in: PubMed
    Score: 0.003
  70. Molecular mechanism underlying partial and full agonism mediated by the human cholecystokinin-1 receptor. J Biol Chem. 2005 Mar 18; 280(11):10664-74.
    View in: PubMed
    Score: 0.003
  71. Intracellular Ca2+ and phorbol esters synergistically inhibit internalization of epidermal growth factor in pancreatic acini. Biochem J. 1984 Nov 01; 223(3):893-900.
    View in: PubMed
    Score: 0.003
  72. Effect of intracellular Ca2+ on insulin-like growth factor II. internalization into pancreatic acini. Roles of insulin and cholecystokinin. J Biol Chem. 1984 Oct 25; 259(20):12350-6.
    View in: PubMed
    Score: 0.003
  73. Regulation of pancreatic acinar cell insulin receptors by insulin. Am J Physiol. 1984 Aug; 247(2 Pt 1):G155-60.
    View in: PubMed
    Score: 0.003
  74. A transforming growth factor beta-induced Smad3/Smad4 complex directly activates protein kinase A. Mol Cell Biol. 2004 Mar; 24(5):2169-80.
    View in: PubMed
    Score: 0.003
  75. Epidermal growth factor: intracellular Ca2+ inhibits its association with pancreatic acini and A431 cells. FEBS Lett. 1983 Dec 12; 164(2):335-9.
    View in: PubMed
    Score: 0.003
  76. Epidermal growth factor binding and biologic effects on mouse pancreatic acini. Gastroenterology. 1983 Aug; 85(2):339-45.
    View in: PubMed
    Score: 0.003
  77. Pancreatic acini in short-term culture: regulation by EGF, carbachol, insulin, and corticosterone. Am J Physiol. 1983 Jun; 244(6):G675-82.
    View in: PubMed
    Score: 0.003
  78. Dominant negative Rab3D inhibits amylase release from mouse pancreatic acini. J Biol Chem. 2002 May 17; 277(20):18002-9.
    View in: PubMed
    Score: 0.003
  79. Adenovirus-mediated gene transfer of dominant-negative Smad4 blocks TGF-beta signaling in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol. 2001 Jun; 280(6):G1247-53.
    View in: PubMed
    Score: 0.003
  80. Distinct cytoplasmic domains of the growth hormone receptor are required for glucocorticoid- and phorbol ester-induced decreases in growth hormone (GH) binding. These domains are different from that reported for GH-induced receptor internalization. J Biol Chem. 1996 Jul 26; 271(30):18088-94.
    View in: PubMed
    Score: 0.002
  81. Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci U S A. 1991 Jan 15; 88(2):429-33.
    View in: PubMed
    Score: 0.001
  82. Monoclonal antibodies as probes for plasma membrane domains in the exocrine pancreas. J Histochem Cytochem. 1988 Aug; 36(8):1043-51.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.